凯龙股份：10月24日召开董事会会议

Group 1 - The company Kailong Co., Ltd. (SZ 002783) announced on October 24 that its ninth board meeting was held to discuss the proposal to reappoint Lixin Certified Public Accountants for the 2025 financial report audit [1] - For the first half of 2025, the revenue composition of Kailong Co., Ltd. is as follows: 34.92% from civil explosive materials, 28.7% from blasting services, 26.74% from ammonium nitrate and compound fertilizers, and 5.83% from other sources, with nano calcium carbonate and stone accounting for 3.81% [1] - As of the report date, the market capitalization of Kailong Co., Ltd. is 5.1 billion yuan [1] Group 2 - The Chinese innovative drug sector has generated $80 billion in overseas licensing deals this year, indicating a hot secondary market for biomedicine, while the primary market is experiencing a fundraising slowdown [1]